KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Long-Term Investments: 2009-2024

Historic Long-Term Investments for Charles River Laboratories International (CRL) over the last 7 years, with Dec 2024 value amounting to $218.3 million.

  • Charles River Laboratories International's Long-Term Investments rose 54.54% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.6 million, marking a year-over-year increase of 54.54%. This contributed to the annual value of $218.3 million for FY2024, which is 10.44% down from last year.
  • According to the latest figures from FY2024, Charles River Laboratories International's Long-Term Investments is $218.3 million, which was down 10.44% from $243.8 million recorded in FY2023.
  • Charles River Laboratories International's Long-Term Investments' 5-year high stood at $311.6 million during FY2022, with a 5-year trough of $24.7 million in FY2020.
  • Over the past 3 years, Charles River Laboratories International's median Long-Term Investments value was $243.8 million (recorded in 2023), while the average stood at $257.9 million.
  • In the last 5 years, Charles River Laboratories International's Long-Term Investments surged by 715.06% in 2021 and then fell by 21.76% in 2023.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Long-Term Investments stood at $24.7 million in 2020, then skyrocketed by 715.06% to $201.4 million in 2021, then spiked by 54.75% to $311.6 million in 2022, then fell by 21.76% to $243.8 million in 2023, then decreased by 10.44% to $218.3 million in 2024.